Skip to main content

7 Result(s)

within Tomohide Tamura Remove this filter Internal Medicine Remove this filter

and

  1. Article

    Open Access

    Pooled Analysis of Studies Evaluating Fosnetupitant and Risk Factors for Cisplatin-Induced Nausea and Vomiting During the Extended Overall Phase

    Fosnetupitant is a novel neurokinin 1 receptor antagonist (NK1RA) with favorable antiemetic efficacy in patients receiving emetogenic chemotherapy. This study assessed the efficacy of fosnetupitant in combination...

    Naoki Inui, Yukihiro Toi, Yasuto Yoneshima, Masahiro Morise… in Advances in Therapy (2023)

    Download PDF (529 KB) View Article

  2. Article

    Open Access

    Findings of virtual bronchoscopic navigation can predict the diagnostic rate of primary lung cancer by bronchoscopy in patients with peripheral lung lesions

    Despite being minimally invasive, bronchoscopy does not always result in pathological specimens being obtained. Therefore, we investigated whether virtual bronchoscopic navigation (VBN) findings were associate...

    Atsushi Kitamura, Yutaka Tomishima, Ryosuke Imai, Naoki Nishimura… in BMC Pulmonary Medicine (2022)

    Download PDF (737 KB) View Article

  3. Article

    Open Access

    Exploratory Analysis Comparing Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blind, Phase 3 Study (CONSOLE)

    We describe the results of an exploratory analysis performed on the first head-to-head study (JapicCTI-194611) comparing two different intravenous (IV) neurokinin 1 (NK1) receptor antagonists, fosnetupitant and f...

    Akito Hata, Yoshimasa Shiraishi, Naoki Inui, Morihito Okada… in Oncology and Therapy (2022)

    Download PDF (370 KB) View Article

  4. No Access

    Article

    Population Pharmacokinetics of Gemcitabine and Its Metabolite in Japanese Cancer Patients

    Gemcitabine (2′,2’-difluorodeoxycytidine) is an anticancer drug, which is effective against solid tumours, including non-small-cell lung cancer and pancreatic cancer. After gemcitabine is transported into cell...

    Emiko Sugiyama, Dr Nahoko Kaniwa, Su-Ryang Kim… in Clinical Pharmacokinetics (2010)

  5. No Access

    Article

    Prognostic factors for malignant pericardial effusion treated by pericardial drainage in solid-malignancy patients

    Malignant pericardial effusion is a frequent complication of advanced incurable malignancies and requires treatment. The purpose of this study was to identify prognostic factors for cytology-positive malignant...

    Kan Yonemori, Hideo Kunitoh, Koji Tsuta, Tetsutaro Tamura, Yasuaki Arai… in Medical Oncology (2007)

  6. No Access

    Chapter

    Clinical Trials for Lung Cancer in Progress in Japan

    Ikuo Sekine, Yuichiro Ohe, Nagahiro Saijo, Tomohide Tamura in Tumors of the Chest (2006)

  7. No Access

    Article

    Prognostic factors in non-small cell lung cancer: multiregression analysis in the National Cancer Center Hospital (Japan)

    A total of 190 patients with unresectable non-small cell lung cancer (NSCLC) were analyzed retrospectively using eight pretreatment and three treatment-related prognostic factors in terms of influence on survi...

    Masanori Sakurai, Tetsu Shinkai… in Journal of Cancer Research and Clinical On… (1987)